JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sawicki, G. J.
Right arrow Articles by Arnsdorf, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sawicki, G. J.
Right arrow Articles by Arnsdorf, M. F.

Electrophysiologic actions and interactions between lysophosphatidylcholine and lidocaine in the nonsteady state: the match between multiphasic arrhythmogenic mechanisms and multiple drug effects in cardiac Purkinje fibers

GJ Sawicki and MF Arnsdorf

The effects and interactions between an arrhythmogenic intervention and an antiarrhythmic drug on active and passive cellular properties relevant to excitability were studied with multiple microelectrode methods and rapid online data analysis in cardiac Purkinje fibers. The arrhythmogenic intervention was superfusion with lysophosphatidylcholine (LPC), a metabolite that accumulates in the ischemic myocardium; and the antiarrhythmic drug was lidocaine. LPC (10- 20 microM) initially increased excitability as manifested by a decreased threshold current and, when tested, by a downward shift in nonnormalized strength- and charge-duration curves. Normalized strength- and charge-duration curves suggested altered passive properties to be primarily responsible for increased excitability. Cable analysis showed LPC to increase significantly input resistance, membrane resistance, time constant and length constant; current-voltage relationships showed LPC to decrease chord and slope conductances over the subthreshold range. Lidocaine (4 micrograms/ml) decreased excitability both by depressing the sodium system and by directly countering the effects of LPC on conductance and related properties. LPC subsequently decreased excitability by depressing the sodium system and, in this phase, the further depressant effect of lidocaine on the sodium system predominated. Lidocaine could normalize action potentials that were prolonged or had two stable steady states after LPC, at times retarded LPC-induced inexcitability and could render the tissue inexcitable to intracellular point stimulation but not to extracellular stimulation. Interactions between the arrhythmogenic and pharmacologic interventions affected net excitability by altering the matrix of active and passive cellular properties in time. The results are relevant to the development of a rational matrical approach to understanding drug action and treating arrhythmias.

Volume 235, Issue 3, pp. 829-838, 12/01/1985
Copyright © 1985 by American Society for Pharmacology and Experimental Therapeutics







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1985 by the American Society for Pharmacology and Experimental Therapeutics.